GEN vs NVCT · P/E 17, rev $5.00B vs $304.5M cap
Gen Digital Inc. (GEN) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
NVCT does not have a complete income-statement cache yet.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the GEN and NVCT stock pages for the full models.
Not investment advice.